ZA826230B - Active compound combination of kitasamycin and quinoxaline di-n-oxides - Google Patents

Active compound combination of kitasamycin and quinoxaline di-n-oxides

Info

Publication number
ZA826230B
ZA826230B ZA826230A ZA826230A ZA826230B ZA 826230 B ZA826230 B ZA 826230B ZA 826230 A ZA826230 A ZA 826230A ZA 826230 A ZA826230 A ZA 826230A ZA 826230 B ZA826230 B ZA 826230B
Authority
ZA
South Africa
Prior art keywords
kitasamycin
oxides
active compound
compound combination
hydrogen
Prior art date
Application number
ZA826230A
Other languages
English (en)
Inventor
Peter Henry Selle
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6140231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA826230(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA826230B publication Critical patent/ZA826230B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA826230A 1981-08-27 1982-08-26 Active compound combination of kitasamycin and quinoxaline di-n-oxides ZA826230B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813133888 DE3133888A1 (de) 1981-08-27 1981-08-27 Wirkstoffkombination aus kitasamycin und chinoxalin-di-n-oxiden

Publications (1)

Publication Number Publication Date
ZA826230B true ZA826230B (en) 1983-07-27

Family

ID=6140231

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA826230A ZA826230B (en) 1981-08-27 1982-08-26 Active compound combination of kitasamycin and quinoxaline di-n-oxides

Country Status (12)

Country Link
EP (1) EP0073390B1 (xx)
JP (1) JPS5852224A (xx)
KR (1) KR860000275B1 (xx)
AT (1) ATE20171T1 (xx)
AU (1) AU552563B2 (xx)
BR (1) BR8205020A (xx)
DE (2) DE3133888A1 (xx)
EG (1) EG15924A (xx)
ES (1) ES515272A0 (xx)
FI (1) FI70364C (xx)
PH (1) PH19663A (xx)
ZA (1) ZA826230B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230273A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Lichtstabilisierte chinoxalin-di-n-oxide
DE3340931A1 (de) * 1983-11-11 1985-05-23 Bayer Ag, 5090 Leverkusen Staubfreie chinoxalin-1,4-di-n-oxide
JPH06701B2 (ja) * 1983-12-01 1994-01-05 旭化成工業株式会社 動物用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535309A (en) * 1967-09-01 1970-10-20 Kitasato Inst Antibiotics and their production
DE1670935C3 (de) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carbonsäureamidochinoxalin-1,4-dl-N-oxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
AT281841B (de) * 1968-10-03 1970-06-10 Bayer Ag Verfahren zur herstellung von neuen 2-methyl-3-carbonsaeureamido-chinoxalindi-n-oxiden-(1,4)
SU890961A3 (ru) * 1976-01-20 1981-12-15 Циба-Гейги Аг (Фирма) Ростстимулирующее средство дл животных
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides

Also Published As

Publication number Publication date
DE3133888A1 (de) 1983-03-10
JPS5852224A (ja) 1983-03-28
AU552563B2 (en) 1986-06-05
BR8205020A (pt) 1983-06-07
ES8400014A1 (es) 1983-10-16
FI822950L (fi) 1983-02-28
KR860000275B1 (ko) 1986-03-26
EP0073390A1 (de) 1983-03-09
DE3271554D1 (en) 1986-07-10
KR840000903A (ko) 1984-03-26
FI70364B (fi) 1986-03-27
ES515272A0 (es) 1983-10-16
FI822950A0 (fi) 1982-08-25
EP0073390B1 (de) 1986-06-04
PH19663A (en) 1986-06-09
AU8774882A (en) 1983-03-03
ATE20171T1 (de) 1986-06-15
FI70364C (fi) 1986-09-19
EG15924A (en) 1986-12-30

Similar Documents

Publication Publication Date Title
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
ES465384A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
MY102277A (en) Quinoline compounds
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
GR3001356T3 (en) 3-vinyl and 3-ethinyl-beta-carboline derivatives, their preparation and their use as medicaments
MY102973A (en) Isoindolinyl alkyl piperazines
ES8401067A1 (es) Procedimiento analogo para preparar un derivado de tropil benzoato.
ZA832887B (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
AU552563B2 (en) Active compound of kitasamycin and quinoxaline di-n- oxides
MX9505054A (es) Derivados de ester de bisfenol.
ES453881A1 (es) Un procedimiento para la produccion de 1,3-ditiolo (4,5-b) pirazin-2-ilidempropanodinitrilo.
GR81580B (xx)
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
ES8401066A1 (es) Derivados de isoquinolina 1,5-sustituidos.
FR2501676B1 (xx)
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
ES469896A1 (es) Procedimiento para la obtencion de derivados de la hidroxi-4tiazolinationa-2
ES456296A1 (es) Procedimiento para la obtencion de nuevos compuestos de imi-no.
GR77967B (xx)
ATE69819T1 (de) 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles mittel.
GR851530B (xx)
ES433081A1 (es) Un procedimiento de preparacion de un compuesto espiro.
ES8300704A1 (es) Un procedimiento para la preparacion del n-oxido del 4 hetoxi-n-(2-(-(imetil-2-piperidil) etil) fenil)benzamida.